RLPC-Valeant nets $15.5 bln debt financing for Allergan buy
April 22, 2014 at 14:06 PM EDT
NEW YORK, April 22 (Reuters) - Valeant Pharmaceuticals has lined up $15.5 billion in debt financing from Barclays and RBC Capital Markets to fund its proposed $47 billion purchase of Allergan Inc., the company said on Tuesday in a press release.